Decision Diagnostics (Decision Diagnostics) Total Stockholders Equity : $-0.05 Mil (As of Sep. 2021)

View and export this data going back to . Start your Free Trial

What is Decision Diagnostics Total Stockholders Equity?

Decision Diagnostics's Total Stockholders Equity for the quarter that ended in Sep. 2021 was $-0.05 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Decision Diagnostics's Book Value per Share for the quarter that ended in Sep. 2021 was $-0.00. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Decision Diagnostics's Debt-to-Equity for the quarter that ended in Sep. 2021 was -62.27.

Decision Diagnostics Total Stockholders Equity Historical Data

The historical data trend for Decision Diagnostics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decision Diagnostics Total Stockholders Equity Chart

Decision Diagnostics Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec17

Dec18

Dec19

Dec20

Total Stockholders Equity

Get a 7-Day Free Trial

0.85

1.64

1.09

0.09

0.48

Decision Diagnostics Quarterly Data
	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec17	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21
Total Stockholders Equity	Get a 7-Day Free Trial															0.26	0.48	0.34	0.04	-0.05

Decision Diagnostics (OTCPK:DECN) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Decision Diagnostics's Book Value per Share for the quarter that ended in Sep. 2021 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-0.052	-	0.001)	/	357.871
	=	-0.00

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Decision Diagnostics's Debt-to-Equity for the quarter that ended in Sep. 2021 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.238	+	0)	/	-0.052
	=	-62.27

Decision Diagnostics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Decision Diagnostics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Decision Diagnostics (Decision Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Decision Diagnostics Corp (OTCPK:DECN) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

2660 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361

Website

http://www.decisiondiagnostics.co

Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.

Executives

Keith Berman	director, officer: Secretary	2660 TOWNSGATE RD #300, WESTLAKE VILLAGE CA 91361
Robert Jagunich	director	765 CHRISTINE DR PALO ALTO CA 94303
Robert Lawrence Cox	director, officer: President